Apple Quietly Acquires Gliimpse to Bolster Ambitions in Digital Health

Apple’s Push into Healthcare AcceleratesAs confirmed by Fast Company, Apple completed its acquisition of Gliimpse, a startup specializing in personal health data processing, earlier this year. Little-known within the industry, Gliimpse has focused on collecting and integrating personal health data from diverse sources. The specific financial terms of the deal remain undisclosed, and neither Apple nor Gliimpse has issued an official statement regarding the acquisition.

According toVCBeat(WeChat: vcbeat) It is understood that Gliimpse, headquartered in the United States, was founded in 2013 and secured only $1 million in seed funding in February 2015. Although the company is small in scale, its ambitions are substantial. Given that medical records and pharmaceutical data systems within the current U.S. healthcare system are largely incompatible and lack a unified sharing format, Gliimpse aims to create “personalized and shareable health data” for every American, as well as for doctors and patients worldwide. Gliimpse allows users to store personal health information in the form of documents or images on a secure online platform, thereby creating private health profiles. Users can, of course, share this data with anyone at their discretion.

Founder Anil Sethi has deep ties with Apple and is a bona fide serial entrepreneur. In the healthcare sector, he has maintained a long-term collaborative partnership with Johns Hopkins University. As early as the 1980s, Sethi served as a systems engineer at Apple. In 2001, he sold Sequoia Software, the company he founded, to Citrix Systems for more than $180 million in cash. Following this successful venture, Sethi went on to establish several health-related technology companies, including Xlipstream, Pinch Bio, and later, Gliimpse.

The acquisition was completed earlier this year, but Apple had not disclosed the news until it confirmed the deal in response to a query from a Fast Company reporter. It remains unclear where Gliimpse will fit within Apple’s organizational structure; however, integration into existing products such as HealthKit, ResearchKit, or CareKit is more likely, given their shared objectives in data collection and organization.

Apple’s Ambitions and Strategic Layout in Healthcare Are Becoming Increasingly SophisticatedOn August 11 this year, Apple filed a new patent related to healthcare with the United States Patent and Trademark Office (USPTO). The patent reveals that Apple is developing a wearable medical device capable of rapidly measuring electrocardiograms (ECG) through a series of built-in sensors. By monitoring body movements and collecting raw data, the device can compare this information with previously stored data, enabling more complex and precise data processing and analysis.

During this year’s second-quarter investor conference call and in its quarterly financial report, Apple CEO Tim Cook highlighted upcoming updates to the Health app in the next iOS release, particularly new medical and fitness features for the Apple Watch. With the launch of watchOS 3 this fall, Apple Watch users will benefit from an enhanced user interface, significantly improved performance, and new fitness and health capabilities, including Activity Sharing.

Even in terms of personnel changes, Apple has strengthened its capabilities by recruiting experts in the healthcare sector. In an interview with Fast Company, Tim Cook stated, “We have entered the health sector, and we will be thinking and planning across areas such as medical research, patient care, and beyond.”